Literature DB >> 18417035

Role of natural killer cells in HIV pathogenesis.

Jeffrey Ward1, Edward Barker.   

Abstract

Although the majority of research on immune cell recognition of HIV-infected cells has focused on CD8+ T cells with an eye towards vaccine development, innate immune recognition by natural killer (NK) cells has become a focus in recent years. Genetic and mechanistic data indicate that NK cells play a role during pathogenesis, and research on NK biology in the context of the broader immune response shows that NK cells are required to mount an effective antiviral response. HIV is able to escape cytotoxic T lymphocyte recognition by downmodulation of major histocompatibility complex class I receptors, which should enhance NK cytotoxicity against infected targets. However, the virus has evolved elaborate mechanisms to evade NK cell responses. Moreover, NK cell function as a whole is compromised through poorly understood mechanisms as a result of viremia. Further work on the role of NK cells during all stages of disease will further our understanding of the immune response against HIV.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18417035     DOI: 10.1007/s11904-008-0008-2

Source DB:  PubMed          Journal:  Curr HIV/AIDS Rep        ISSN: 1548-3568            Impact factor:   5.071


  49 in total

1.  The selective downregulation of class I major histocompatibility complex proteins by HIV-1 protects HIV-infected cells from NK cells.

Authors:  G B Cohen; R T Gandhi; D M Davis; O Mandelboim; B K Chen; J L Strominger; D Baltimore
Journal:  Immunity       Date:  1999-06       Impact factor: 31.745

2.  Targeted lysis of HIV-infected cells by natural killer cells armed and triggered by a recombinant immunoglobulin fusion protein: implications for immunotherapy.

Authors:  Neil Gupta; James Arthos; Prateeti Khazanie; Tavis D Steenbeke; Nina M Censoplano; Eva A Chung; Catherine C Cruz; Margery A Chaikin; Marybeth Daucher; Shyam Kottilil; Domenico Mavilio; Peter Schuck; Peter D Sun; Ronald L Rabin; Sergei Radaev; Donald Van Ryk; Claudia Cicala; Anthony S Fauci
Journal:  Virology       Date:  2005-02-20       Impact factor: 3.616

Review 3.  Effector and regulatory events during natural killer-dendritic cell interactions.

Authors:  Lorenzo Moretta; Guido Ferlazzo; Cristina Bottino; Massimo Vitale; Daniela Pende; Maria Cristina Mingari; Alessandro Moretta
Journal:  Immunol Rev       Date:  2006-12       Impact factor: 12.988

4.  Distinctive NK-cell receptor repertoires sustain high-level constitutive NK-cell activation in HIV-exposed uninfected individuals.

Authors:  Sophie Ravet; Daniel Scott-Algara; Elodie Bonnet; Hung Khiem Tran; Ton Tran; Ngai Nguyen; Lien Xuan Truong; Ioannis Theodorou; Françoise Barré-Sinoussi; Gianfranco Pancino; Pascale Paul
Journal:  Blood       Date:  2007-02-01       Impact factor: 22.113

5.  HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C.

Authors:  V M Braud; D S Allan; C A O'Callaghan; K Söderström; A D'Andrea; G S Ogg; S Lazetic; N T Young; J I Bell; J H Phillips; L L Lanier; A J McMichael
Journal:  Nature       Date:  1998-02-19       Impact factor: 49.962

6.  HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes.

Authors:  K L Collins; B K Chen; S A Kalams; B D Walker; D Baltimore
Journal:  Nature       Date:  1998-01-22       Impact factor: 49.962

7.  Human cytomegalovirus infection is associated with increased proportions of NK cells that express the CD94/NKG2C receptor in aviremic HIV-1-positive patients.

Authors:  Monica Gumá; Cecilia Cabrera; Itziar Erkizia; Margarita Bofill; Bonaventura Clotet; Lidia Ruiz; Miguel López-Botet
Journal:  J Infect Dis       Date:  2006-05-24       Impact factor: 5.226

8.  Imprint of human cytomegalovirus infection on the NK cell receptor repertoire.

Authors:  Mónica Gumá; Ana Angulo; Carlos Vilches; Natalia Gómez-Lozano; Núria Malats; Miguel López-Botet
Journal:  Blood       Date:  2004-08-10       Impact factor: 22.113

9.  Lack of KIR3DS1 binding to MHC class I Bw4 tetramers in complex with CD8+ T cell epitopes.

Authors:  Geraldine M A Gillespie; Arman Bashirova; Tao Dong; Daniel W McVicar; Sarah L Rowland-Jones; Mary Carrington
Journal:  AIDS Res Hum Retroviruses       Date:  2007-03       Impact factor: 2.205

10.  Natural killer cells promote early CD8 T cell responses against cytomegalovirus.

Authors:  Scott H Robbins; Gilles Bessou; Amélie Cornillon; Nicolas Zucchini; Brigitte Rupp; Zsolt Ruzsics; Torsten Sacher; Elena Tomasello; Eric Vivier; Ulrich H Koszinowski; Marc Dalod
Journal:  PLoS Pathog       Date:  2007-08-24       Impact factor: 6.823

View more
  5 in total

Review 1.  Functions of IL-15 in anti-viral immunity: multiplicity and variety.

Authors:  Katherine C Verbist; Kimberly D Klonowski
Journal:  Cytokine       Date:  2012-06-15       Impact factor: 3.861

2.  Role of natural killer cells in a cohort of elite suppressors: low frequency of the protective KIR3DS1 allele and limited inhibition of human immunodeficiency virus type 1 replication in vitro.

Authors:  Karen A O'Connell; Yefei Han; Thomas M Williams; Robert F Siliciano; Joel N Blankson
Journal:  J Virol       Date:  2009-02-11       Impact factor: 5.103

3.  Low CD4+ T cell counts among African HIV-1 infected subjects with group B KIR haplotypes in the absence of specific inhibitory KIR ligands.

Authors:  Wim Jennes; Sonja Verheyden; Christian Demanet; Joris Menten; Bea Vuylsteke; John N Nkengasong; Luc Kestens
Journal:  PLoS One       Date:  2011-02-14       Impact factor: 3.240

4.  NK cell receptor/H2-Dk-dependent host resistance to viral infection is quantitatively modulated by H2q inhibitory signals.

Authors:  Nassima Fodil-Cornu; J Concepción Loredo-Osti; Silvia M Vidal
Journal:  PLoS Genet       Date:  2011-04-21       Impact factor: 5.917

5.  FcγRIIIa receptor polymorphism influences NK cell mediated ADCC activity against HIV.

Authors:  Sneha Pramod Talathi; Nawaj Najir Shaikh; Sudhanshu Shekhar Pandey; Vandana Ashish Saxena; Megha Sunil Mamulwar; Madhuri Rajeev Thakar
Journal:  BMC Infect Dis       Date:  2019-12-16       Impact factor: 3.090

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.